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Yousef and colleagues\' article discussing the value of monitoring serum leptin in critically ill patients touches on the important matter of early diagnosis and differentiation between sepsis and non-infectious systemic inflammatory response syndrome (SIRS) \[[@B1]\]. The early diagnosis of sepsis, the identification of its origin, and an adequate therapeutic management are crucial to overcome sepsis-associated mortality \[[@B2]\].

Cytokine levels are the obvious choice as sepsis markers since cytokines are key mediators of the inflammatory response to sepsis. Among the cytokines, TNFα, IL-1, IL-6, IFNγ, IL-10, and IL-13 best characterize the immune dysregulation during sepsis \[[@B3]\].

In 1998 Bornstein and colleagues reported an increase in leptin levels and the loss of the diurnal rhythm of this adipokine in survivors of acute sepsis \[[@B4]\]. They also observed that low leptin and high IL-6 levels indicated an unfavorable prognosis in patients with sepsis syndrome. Owing to contradictory findings in latter reports \[[@B5]-[@B9]\], however, the interest in leptin as a sepsis marker waned.

Leptin, a hormone mainly generated by adipocytes, acts centrally in the hypothalamus to regulate body weight and energy expenditure. There is, however, strong evidence that leptin is also involved in cell-mediated immunity and cytokine crosstalk \[[@B10]\].

Yousef and colleagues confirmed a positive correlation between leptin and IL-6 and TNFα in patients with sepsis \[[@B11]\]. The finding that a serum leptin threshold of 38 μg/l can distinguish between sepsis and non-infectious SIRS (sensitivity 91.2%, specificity 85%) is the major finding in the article by Yousef and colleagues (in this issue).

The matter at heart in the early differentiation between sepsis and non-infectious SIRS is the impact on outcome. In patients with surgically confirmed secondary peritonitis, our group found that a serum level of leptin \<10 ng/ml was accompanied by a 4.25-fold increase in the risk of death. Our results were limited to moderate to severe peritonitis where the measurement was made 24 hours into the postoperative period (± 2 hours) \[[@B12]\]. Since leptin apparently inhibits an excessive or harmful lipopolysaccharide-induced inflammatory reaction to or prevents TNFα-induced lethality in sepsis \[[@B13]\], it would have been interesting if Yousef and colleagues had reported the results of the 11 patients that died in their study group \[[@B1]\]. Our findings \[[@B12]\] concur with those reported by Bornstein and colleagues: an increase is found in leptin serum levels in septic patients, while a low leptin level is associated with a negative outcome \[[@B4]\] - possibly due to the lack of the protective effect of leptin \[[@B13]\].

Yousef and colleagues\' report contributes to our understanding of the regulation of the inflammatory cascade in sepsis \[[@B1]\]. Much remains to be learned about the precise mechanisms by which leptin signaling participates in sepsis and non-infectious SIRS. This knowledge will potentially contribute to new therapeutic approaches.
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